(lp0
S'Novelion Therapeutics Observes Rare Disease Day GlobeNewswire  - Feb 28, 2017 28, 2017  -- Novelion Therapeutics Inc.  , a biopharmaceutical company dedicated to developing new standards of care for individuals living with rare diseases, today announced today its alliance with the National ...'
p1
aS'Novelion Therapeutics Reports Preliminary Fourth Quarter &amp; Full Year 2016 ... GlobeNewswire  - Mar 15, 2017 VANCOUVER, British Columbia, March 15, 2017  -- Novelion Therapeutics Inc.  , a biopharmaceutical company dedicated to developing new standards of care for individuals living with rare diseases ... Pro forma net ...Novelion Therapeutics reports 4Q loss - Yahoo FinanceNovelion Therapeutics Inc.  Files An 8-K Results of Operations ... - Market Exclusive'
p2
aS'Novelion Therapeutics Inc.  Files An 8-K Other Events Market Exclusive - Mar 7, 2017 Novelion Therapeutics Inc, formerly QLT Inc., is a Canada-based biopharmaceutical company. The Company is engaged in development of new standards of care for individuals living with rare diseases.Novelion Therapeutics  Lomitapide Patents Affirmed with Favorable IPR ... - StreetInsider.comNovelion prevails in challenge to lomitapide patents - Seeking Alpha'
p3
aS'Shares in Review: Watching the Levels for Novelion Therapeutics Inc.  Sherwood Daily - 13 hours ago Checking the Value Composite score for Novelion Therapeutics Inc. , we see that the company has a rank of 81. This falls on a scale from 0 to 100 where a lower score indicated an undervalued company and a higher score would indicate an&nbsp;...'
p4
aS'Novelion Therapeutics Announces Presentation at the 29th Annual ROTH Conference GlobeNewswire  - Mar 8, 2017 VANCOUVER, British Columbia and CAMBRIDGE, Mass., March 08, 2017  -- Novelion Therapeutics, Inc.  , a biopharmaceutical company dedicated to developing new standards of care for individuals living&nbsp;...'
p5
aS"Will Novelion Therapeutics Inc.  continue to beat earnings? Post Analyst - Mar 22, 2017 Novelion Therapeutics Inc.  is trading down on a volume of 0.09 million, or 0.75 times its standard daily volume.Stock within Traders Observation: Novelion Therapeutics Inc.'s  - Is stories"
p6
aS"Gerdau SA   Reaches $3.63 After 4.00% Down Move; Novelion ... Wolcott Daily - Mar 23, 2017 With 60,400 avg volume, 6 days are for Novelion Therapeutics Incorporated 's short sellers to cover NVLN's short positions."
p7
aS'Inspyr Therapeutics Signs Commitment Letter with Milost Global Nasdaq - 18 hours ago WESTLAKE VILLAGE, Calif., March 28, 2017  -- Inspyr Therapeutics , a clinical-stage biotechnology company developing a novel prodrug therapeutic for the treatment of cancer, announced today that the Company ... Mipsagargin ...'
p8
aS"Stock Movements Activity: Novelion Therapeutics Inc.'s  Is stories - Mar 2, 2017 Novelion Therapeutics Inc.'s  witnessed a gain of 4.05% in recent trading period with closing price of $ 10.80. The company's last traded volume of 0.2 million shares as compared to it's an average volume of 0.18 million shares."
p9
aS'Proteostasis Therapeutics Inc.  Soars 10.01% on March 27 Equities.com - Mar 27, 2017 Proteostasis Therapeutics Inc.  had a good day on the market for Monday March 27 as shares jumped 10.01% to close at $11.43.Proteostasis Therapeutics Inc  Upgraded to Hold by Zacks Investment ... - BNB Daily '
p10
a.